⚠️ Not investment advice. This is a quantitative research tool; every decision is the user's own responsibility. Past performance does not guarantee future results.⚠️ Not investment advice. Past performance does not guarantee future results.
⚠️ Not investment advice. Past performance does not guarantee future results.
🔓 Sign up freeSee the full rankingSign in with Google
← Back to the full ranking · All companies

Kerry Group KRZ.IR

Ireland Consumer Defensive
5.8/10
AI Analyst score
85.95 EUR
Last price at analysis date · analyst target 99.00 (+15.2%)
🛒 Where to buy KRZ.IRIreland
No partner-broker fees for this market yet · Broker cost comparison →
🟡 HOLD — Hold positions: valuation is reasonable (P/E 21.87) with positive momentum (score 6.7) and credible 2030 targets, but no immediate catalyst to overcome growth weakness.

Kerry Group is an Irish food ingredients and flavors company that supplies products to the food and beverage industry, with a business model focused on innovation and customized solutions for global clients. Kerry Group shows solid financial health (score 6.68) with controlled debt (ND/EBITDA 1.95) and adequate liquidity (1.76), although growth is negative (revenue -3.70%) and free cash flow conversion is weak (24.38).

Financial health
6.7
Quality / Moat
4.9
Valuation
5.4
Growth
3.3
Dividend
6.2
Momentum
6.7
Risk & Context
7.8

Detailed metrics

Market and fundamental data as of the analysis date.

💵 Valuation
P/E21.87
Fwd P/E15.25
EV/EBITDA13.90
P/B2.24
P/S2.06
PEG1.29
Market cap13.66 B EUR
Enterprise value15.82 B EUR
🏰 Quality and moat
ROIC (approx.)8.8%
Gross margin50.22%
FCF conversion24%
Operating margin11.90%
📈 Profitability and margins
ROE10.61%
ROA4.91%
Net margin9.62%
FCF277.6 M EUR
FCF yield2.03%
🏦 Solvency and liquidity
Total debt2.83 B EUR
Net debt2.22 B EUR
Cash604.5 M EUR
EBITDA1.14 B EUR
Net debt / EBITDA1.95
D/E46.21
Current ratio1.76
Quick ratio1.13
🚀 Growth
Revenue growth-3.70%
Earnings growth-3.80%
EPS (TTM)3.93 EUR
EPS (Fwd)5.63 EUR
💰 Dividend and risk
Dividend yield1.68%
Payout35.7%
Beta0.57
Analyst consensusBuy (12)
Target price99.00 EUR
52-week range64.30 EUR – 89.25 EUR
⚠️ Main risk: Declining revenue and earnings (-3.70% and -3.80%) may indicate market share loss or weak demand in the ingredients business, not offset by recent momentum.
See the full analysis and compare with the rest of the ranking →

Full AI report

Generated automatically from the metrics, the macro context and the company's news.

Kerry Group is an Irish food ingredients and flavors company that supplies products to the food and beverage industry, with a business model focused on innovation and customized solutions for global clients. Kerry Group shows solid financial health (score 6.68) with controlled debt (ND/EBITDA 1.95) and adequate liquidity (1.76), although growth is negative (revenue -3.70%) and free cash flow conversion is weak (24.38).

Score by category

CategoryScore
Financial health6.7
Quality / Moat4.9
Valuation5.4
Growth3.3
Dividend6.2
Momentum6.7
Risk & Context7.8

OVERALL SCORE: 5.8/10

Context and risks

Domiciled in Ireland with moderate governance risk. No direct relevant geopolitical exposure; the business is global and diversified.

News considered in the analysis

  • Kerry upgraded as Citi sees returns-led upside in ingredients — Upgrade de Citi con tesis de retorno sobre ventas, señal positiva moderada ya parcialmente reflejada en el precio.
  • All You Need to Know About Kerry Group (KRYAY) Rating Upgrade to Buy — Segundo upgrade consecutivo (Zacks) que refuerza el sentimiento alcista, aunque sin catalizador nuevo material.
  • Kerry Group PLC (KRYAF) (Q2 2026) Earnings Call Highlights: Strong Performance and Strategic ... — Resultados del 2T con desempeño fuerte y avance estratégico, consistente con el guidance de márgenes.
  • Kerry Group Targets Higher Margins, 3%-5% Growth and €3.5B Cash Flow by 2030 — Objetivos a 2030 creíbles y accionables, aunque a largo plazo y con probabilidad no total de cumplimiento.
  • Kerry Group Q2 Earnings Call Highlights — Titular redundante sin información adicional relevante.

Verdict: Hold positions: valuation is reasonable (P/E 21.87) with positive momentum (score 6.7) and credible 2030 targets, but no immediate catalyst to overcome growth weakness.

Main risk: Declining revenue and earnings (-3.70% and -3.80%) may indicate market share loss or weak demand in the ingredients business, not offset by recent momentum.

Other Consumer Defensive companies

Neighbours in the sector ranking, to compare without going back to the index.

See all 1,000+ companies in the index →

Automatically generated analysis from fundamental, market and news data. Not personalised financial advice — a research tool, not an individual recommendation. Past performance does not guarantee future results. Last update of this analysis: 2026-09-28. Legal notice, privacy & cookies.